Both in Pharmaceuticals
Obsidian Therapeutics vs Jade Biosciences
Over the past year OBX returned −18.9% and JBIO returned −22.1%; their daily moves had a correlation of 0.56.
OBX −18.9% JBIO −22.1%Growth of $1, one year, split-adjusted
| Metric | OBX | JBIO |
|---|---|---|
| Price | $14.43 | $13.93 |
| Market cap | $891.4M | $885.9M |
| Today | −2.43% | −0.92% |
| 1 month | +6.2% | −1.3% |
| 6 months | — | −43.2% |
| Year to date | — | −9.7% |
| 1 year | — | +41.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $461.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 51.4% |
| Short % of float | 2.2% | 20.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).